Epstein-Barr virus dacryoadenitis - 05/09/11
, Dan B Jones, MD aAbstract |
PURPOSE:
To describe the clinical features of lacrimal gland inflammation associated with Epstein-Barr virus infection.
METHODS:
The clinical records, laboratory data, and radiographs of patients who had inflammation of one or both lacrimal glands that had begun less than 4 weeks previously were reviewed.
RESULTS:
Sixteen patients with dacryoadenitis were encountered between 1980 and 1996, a cumulative frequency of approximately one case per 10,000 new ophthalmic outpatients. Six individuals had serologic or other evidence of recent Epstein-Barr virus infection and were distinguished by the presence of regional lymphadenopathy, no purulent discharge, and a duration of symptoms of 6 weeks.
CONCLUSION:
Epstein-Barr virus is a probable cause of unilateral and bilateral dacryoadenitis in young adults.
Le texte complet de cet article est disponible en PDF.Plan
 | This study was supported in part by grant EY00377 from the National Eye Institute, Bethesda, Maryland; the Sid Richardson Foundation, Houston, Texas; and Research to Prevent Blindness, Inc, New York, New York. Dr Wilhelmus is an RPB Senior Scientific Investigator. |
Vol 129 - N° 3
P. 372-375 - mars 2000 Retour au numéro
Article précédent
- Aspirin use and the prevention of acute ischemic cranial nerve palsy
- Lenworth N Johnson, Steven W Stetson, Gregory B Krohel, Cheryl L Cipollo, Richard W Madsen
- Cello KE, Nelson-Quigg JM, Johnson CA. Frequency doubling technology perimetry for detection of glaucomatous visual field loss. Am J Ophthalmol 2000;129:314–322.
- Wallace L.M Alward
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?